Cost-effectiveness of treatment of diabetic macular edema. - Wikidata - awgldk - TriplyDB

Cost-effectiveness of treatment of diabetic macular edema.

Cost-effectiveness of treatment of diabetic macular edema.

http://www.wikidata.org/entity/Q33606611

about

Productivity costs in patients with refractory chronic rhinosinusitis.Diabetic Retinopathy: A Position Statement by the American Diabetes Association.Retinal Imaging Techniques for Diabetic Retinopathy Screening.[National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up Emerging drugs for diabetic macular edema.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.Visual impairment and blindness in type 2 diabetics: Ife-Ijesa diabetic retinopathy study.Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol.Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema.

P2860

Q34017260-46273DDD-16BB-4100-9BE0-ADBCE5AC6D09 Q34551730-A8DCFF98-1007-4999-8BD6-10CECEF70043 Q35910183-636A4B7C-5F88-48B6-BBE2-AF5BCF83E59D Q36063335-34D19B97-6B39-49E6-B2CE-E2BF65371341 Q36095304-2E0AB821-DE8A-46EB-BE88-E6A83F091E0B Q38241679-1EA87D40-5839-4BBD-ADB1-576A788F31C2 Q38622256-16E083E1-7A06-487E-9906-7915B96AB91E Q39593443-24EB99A4-5663-4C73-A5F4-68420D5A7CDD Q40355154-F16C60FF-F942-46FC-A57B-0A75F8673A08 Q41678993-081FDD9C-00CE-4834-87EE-8CD01B1194B6 Q42150402-7C001FE7-F766-4A72-A629-6038D619ABB2 Q48021105-3A4DEC8E-7390-4046-9679-F94B0E74B0A1

P2860

Cost-effectiveness of treatment of diabetic macular edema.

http://www.wikidata.org/entity/Q33606611

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cost-effectiveness of treatment of diabetic macular edema.

@ast

Cost-effectiveness of treatment of diabetic macular edema.

@en

type

label

Cost-effectiveness of treatment of diabetic macular edema.

@ast

Cost-effectiveness of treatment of diabetic macular edema.

@en

prefLabel

Cost-effectiveness of treatment of diabetic macular edema.

@ast

Cost-effectiveness of treatment of diabetic macular edema.

@en

P1433

Q33606611-E69F7BD6-39D6-4D01-8D2F-332D31F37F66

P1476

Q33606611-2394BC13-233B-4C44-8FE2-42510123A015

P2093

Q33606611-5949F7B8-4DCC-41EB-86A5-FEBA2B518D3D

Q33606611-7ABCEA71-4649-40A7-B006-BD6E9D874161

Q33606611-860EB51B-646B-4045-8A1A-A994A6B2BF78

P2860

Q33606611-00F57C7D-6751-45C0-A268-4D0EB3ED1453

Q33606611-02833760-2A04-403F-A819-36F5DBC3912B

Q33606611-04F8410F-A279-47A9-92CC-4CC825C35445

Q33606611-0ACFF816-CAF6-4396-ADFF-D530D49FDD5F

Q33606611-0B54497E-D0F9-45C5-AB62-6EBF1F8843D5

Q33606611-0E2D62C6-29DD-41F9-958D-A4514ADECB19

Q33606611-10AA21EE-6FFF-4F74-B35F-D3A6BE29E941

Q33606611-26EB22DD-F306-4F55-B9B0-1D8B7C41C3FF

Q33606611-28C98D13-BD56-478B-9BAE-6BFD69544E5D

Q33606611-2F92ACBE-D478-45A4-9566-A03A56225C9D

P304

Q33606611-96949AE2-E85F-4E2A-87D5-562C490095B4

P31

Q33606611-93139E7A-1B88-4A0F-948D-5E76BE7F788F

P356

Q33606611-B825577D-A1B9-4433-8447-EB1858DBE5DB

P407

Q33606611-15E223BA-457B-4421-8E50-8F20F79FC796

P433

Q33606611-69422F86-42AC-4A1C-97D4-8B764AA9A631

P478

Q33606611-8D939C57-A9AF-4085-B01D-1A8F0D912442

P50

Q33606611-7782EAB6-0DDD-47DD-8F85-37DE192E3D63

Q33606611-fff7a7e4-4c5a-2e7b-fcc7-ee9ca3bfdbb3

P577

Q33606611-3B1DB2C5-3F75-4F29-AC7E-47DE050BB87E

P698

Q33606611-3FFA0231-E6D9-46D0-AB40-912C725B3A42

P932

Q33606611-C1116D37-4036-4ADC-B3BD-39674651021F

P356

P1433

Annals of Internal Medicine

P1476

Cost-effectiveness of treatment of diabetic macular edema.

@en

P2093

Brian Matesic

http://www.w3.org/2001/XMLSchema#string

Douglas K Owens

http://www.w3.org/2001/XMLSchema#string

Suzann Pershing

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis.

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

A severity scale for diabetic macular edema developed from ETDRS data.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

P304

18-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/M13-0768

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy Goldhaber-Fiebert

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24573663

http://www.w3.org/2001/XMLSchema#string

P932

4020006

http://www.w3.org/2001/XMLSchema#string